NEW YORK (GenomeWeb news) – Olink Bioscience said today that it has signed up Immuno Diagnostic to distribute its in situ protein detection systems in Finland.

Under the agreement, the Finnish company Immuno Diagnostic will distribute the Duolink in situ PLA product line, which is a proximity ligation assay technology that is used to detect proteins and their interactions and modifications. The technology allows for detection of target proteins with single-molecule resolution, Uppsala, Sweden-based Olink said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.